Al Zimmerman joins as CEO whereas founder Dr. Kane Miller leads growth of Axitan’s tech platform
29 January 2024
3 minute learn
Axitan UK Restricted, a number one biotech firm targeted on the event of endolysin enzyme merchandise to interchange antibiotics in animal feed, is happy to announce the appointment of Alfred (Al) Zimmerman as its new Chief Govt Officer.
Zimmerman brings a wealth expertise from the biotech and animal feed additive industries to Axitan. Axitan’s founder and former CEO, Dr. Kane Miller, will proceed to steer the growth of the Firm’s expertise platform, and related end-market merchandise, within the newly shaped place of Chief Innovation Officer.
Dr Kane Miller, founder and Chief Innovation Officer, mentioned: “Al’s trade perception and confirmed observe file of constructing companies inside the animal feed sector brings the fitting stability to Axitan’s senior administration group as we transition into the total commercialization section. His enthusiasm for introducing new applied sciences and merchandise, mixed along with his business and working expertise, can be instrumental in driving Axitan’s commercialization efforts for our endolysin platform and merchandise.”
Mr. Zimmerman was beforehand with Novus Worldwide from 2015-2023 and lately led innovation development technique, enterprise improvement, acquisitions and alliances. Previous to Novus, Mr. Zimmerman established and led the Dietary Complement Completed Format Enterprise at DuPont (now IFF).
Throughout his tenure at DuPont, which was targeted on growing probiotics for people and animals, he oversaw the event of the probiotic manufacturing platform inside the US and the completed format manufacturing platform globally.
Commenting on his appointment as CEO, Mr. Zimmerman, mentioned: “I’m significantly honored to be becoming a member of Axitan. Kane and his group have developed an distinctive expertise platform based mostly on the Firm’s core endolysin experience. They’ve likewise developed a stable operational basis and, in FORC3®, have launched a ground-breaking product to the market. I stay up for working with them to additional advance the platform and speed up the Firm’s business improvement, constructing on the early momentum already seen from inside the livestock trade for its merchandise.”
Since its formation, Axitan’s biotech group pioneered the event and incorporation of endolysins into animal feed because the mechanism of alternative for concentrating on and eliminating pathogens traditionally managed via antibiotics in animal feed. The Firm formulates its endolysins into nutrient wealthy merchandise to offer materials efficiency advantages to livestock farmers along with pathogen mitigation.
Axitan has already efficiently developed the power to specific endolysins in microalgae and is at the moment engaged on novel bacterial methods to ship endolysin based mostly options with enhanced dietary well being results for concentrating on each gram unfavorable and gram constructive pathogens. Axitan is concentrated on growing answer stacks for the monogastric and aqua markets in addition to leveraging its platform into different species.
From January 30 to February 1, 2024, Axitan can be exhibiting on the poultry trade’s premier trade occasion, the Worldwide Manufacturing and Processing Expo (IPPE), Atlanta, Georgia, stand A959, to showcase its poultry merchandise, FORC3® and NMAN®, in addition to its Partnership companies. To rearrange a gathering with Al Zimmerman or Dr Kane Miller at IPPE, please contact [email protected].
